Immunosuppressive therapy before and during pregnancy may improve obstetric outcomes in pregnancy complicated by dermatomyositis with anti-MDA-5 antibody positivity: A case report

• Главные авторы: Hiroyuki Goto (Автор), Kimito Kawahata (Автор), Akiko Shida (Автор), Saeko Nakagane (Автор), Hitoshi Isohata (Автор), Yu Yamazaki (Автор), Yoshihiro Yoshimura (Автор), Kyoko Hattori (Автор), Kazuki Sekiguchi (Автор), Ryuzo Ishikawa (Автор), Yoko Onishi (Автор), Yuji Kanai (Автор), Nobuya Unno (Автор), Daigo Ochiai (Автор)
• Формат: ‌
• Опубликовано: Elsevier, 2023-03-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Dermatomyositis (DM) is one of the most common autoimmune rheumatic diseases affecting women of childbearing age. Pregnancy may lead to exacerbation of DM, especially of DM with anti-melanoma differentiation-associated gene (MDA) 5 antibody positivity, leading to a poor obstetric outcome. Here, we r...